Vicplas International Ltd
SGX:569
Intrinsic Value
VicPlas International Ltd. operates as an investment holding company, which engages in the research, design, development, and manufacture of medical devices and plastic building products. [ Read More ]
The intrinsic value of one Vicplas International Ltd stock under the Base Case scenario is 0.239 SGD. Compared to the current market price of 0.115 SGD, Vicplas International Ltd is Undervalued by 52%.
Valuation Backtest
Vicplas International Ltd
Run backtest to discover the historical profit from buying and selling Vicplas International Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Vicplas International Ltd
Current Assets | 66.9m |
Cash & Short-Term Investments | 4.5m |
Receivables | 46.6m |
Other Current Assets | 15.9m |
Non-Current Assets | 59.7m |
Long-Term Investments | 1.8m |
PP&E | 56.3m |
Intangibles | 1.6m |
Other Non-Current Assets | 74k |
Current Liabilities | 31.2m |
Accounts Payable | 9.3m |
Short-Term Debt | 13.4m |
Other Current Liabilities | 8.5m |
Non-Current Liabilities | 18.7m |
Long-Term Debt | 15.5m |
Other Non-Current Liabilities | 3.2m |
Earnings Waterfall
Vicplas International Ltd
Revenue
|
113.9m
SGD
|
Cost of Revenue
|
-55.2m
SGD
|
Gross Profit
|
58.7m
SGD
|
Operating Expenses
|
-55.1m
SGD
|
Operating Income
|
3.6m
SGD
|
Other Expenses
|
-1.6m
SGD
|
Net Income
|
2m
SGD
|
Free Cash Flow Analysis
Vicplas International Ltd
Profitability Score
Profitability Due Diligence
Vicplas International Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Vicplas International Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Vicplas International Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Vicplas International Ltd's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Vicplas International Ltd
According to Wall Street analysts, the average 1-year price target for Vicplas International Ltd is 0.27 SGD .
Shareholder Return
Price
Vicplas International Ltd
Average Annual Return | 43.52% |
Standard Deviation of Annual Returns | 84.9% |
Max Drawdown | -83% |
Market Capitalization | 61.8m SGD |
Shares Outstanding | 510 627 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
VicPlas International Ltd. operates as an investment holding company, which engages in the research, design, development, and manufacture of medical devices and plastic building products. The firm designs, develops and manufactures sterile and non-sterile medical devices through its subsidiaries, Forefront Medical Technology (Pte) Ltd, Forefront Medical Investment Pte. Ltd. and XentiQ (Pte.) Ltd. in Singapore; Forefront (Xiamen) Medical Devices Co., Ltd and Forefront Medical Technology (Jiangsu) Co., Ltd in China; and Arrow Medical Limited in the United Kingdom. The firm manufactures and distributes piping systems for diverse industries, including waste and potable water systems for residential homes, schools, commercial and industrial buildings; underground electrical and internal building wire piping systems; and data and signal line piping systems by telecommunications companies, through its subsidiaries, Vicplas Holdings Pte Ltd in Singapore and Rimplas Industries Sdn. Bhd. in Malaysia.
Officers
The intrinsic value of one Vicplas International Ltd stock under the Base Case scenario is 0.239 SGD.
Compared to the current market price of 0.115 SGD, Vicplas International Ltd is Undervalued by 52%.